Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

OBJECTIVE: Patients with short bowel syndrome (SBS) and colon in continuity have better adaptation potential compared with patients with jejunostomy. Adaptation may involve enhanced postprandial secretion of the enteroendocrine hormones glucagon-like peptide (GLP)-1 and GLP-2 which are normally degr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open Gastroenterol
Päätekijät: Naimi, Rahim Mohammad, Hvistendahl, Mark Krogh, Thomassen, Lise Margrete, Johnsen, Hanna, Christiansen, Charlotte Bayer, Holst, Jens Juul, Hartmann, Bolette, Jeppesen, Palle Bekker
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Intestinal Failure
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117993/
https://ncbi.nlm.nih.gov/pubmed/33975891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2021-000604
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia